Mild Hypersensitivities & Atopic Responses

Allergic Rhinitis (Hay Fever)

Type I IgE-Mediated Nasal Mucosal Hypersensitivity

Primary risk age: Preschoolers through Adolescents (Rarely diagnosed before 2 years of age)

Urgency: Mild
Typical age: Preschoolers through Adolescents (Rarely diagnosed before 2 years of age)
Body system: Immunological & Allergic

Typical course: Seasonal symptoms vary with pollen counts; daily medication provides relief within hours (antihistamines) to days (nasal steroids).

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Type I IgE-Mediated Nasal Mucosal Hypersensitivity

Pathophysiology (Development Path)

Inhaled allergens bind to IgE antibodies on nasal mast cells, triggering the release of histamine and leukotrienes. This causes immediate mucosal vasodilation, vascular permeability, and mucus production (early phase). Late-phase inflammation recruits eosinophils, driving chronic nasal congestion.

Primary Causes & Etiology

Inhaled environmental allergens: seasonal (pollen from trees, grass, weeds) or perennial (dust mites, mold, pet dander).

2. Symptom Continuum

Early Onset Signs
Paroxysmal sneezing, clear watery rhinorrhea, and itching of the nose, eyes, and palate.
Progressive Phase
Persistent nasal congestion, mouth breathing, post-nasal drip causing a nighttime cough, and dark circles under the eyes ("allergic shiners" due to venous stasis).
Severe Indicators
Chronic sinus pressure, fatigue, headache, decreased sense of smell, "allergic salute" (transverse nasal crease from pushing the nose upward), and eczema or asthma flares.

3. Clinical Verification

Clinical diagnosis based on history and typical exam findings (pale, boggy, bluish nasal turbinates). Confirm triggers with skin prick testing or allergen-specific IgE blood tests.

4. Care & Elements Plan

Primary Care Treatment Plan

Identify and avoid triggers. Use intranasal corticosteroids as first-line therapy for chronic symptoms, and non-sedating oral antihistamines for acute itching and sneezing.

Home Support Elements

Keep windows closed during high pollen seasons. Use dust mite-proof covers on pillows and mattresses. Vacuum regularly with a HEPA filter. Perform saline nasal rinses.

Generic Active Ingredients (No Brands)

Fluticasone propionate (generic nasal corticosteroid active ingredient to suppress mucosal inflammation)
Cetirizine or Loratadine (generic non-sedating H1-antihistamine active ingredients).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Consult a pediatrician if symptoms interfere with your child's sleep, school performance, or are accompanied by recurrent ear or sinus infections.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Limit exposure to environmental allergens; maintain low humidity in the home to prevent mold and dust mites.

Immunization Context

Allergen immunotherapy (allergy shots or sublingual tablets) is available to desensitize the immune system over time.

7. Timelines & Outlook

Active Timeline

Seasonal symptoms vary with pollen counts; daily medication provides relief within hours (antihistamines) to days (nasal steroids).

Expected Prognosis

Excellent for symptom control, though the condition is chronic and requires ongoing management.

Potential Untreated Complications

Chronic sinusitis, otitis media, worsening asthma control, sleep disruption, and dental malocclusion (from chronic mouth breathing).

Emergency

Anaphylaxis (Pediatric)

Acute Systemic IgE-Mediated Hypersensitivity Reaction

All pediatric ages (Infants and young children have unique symptom presentations)

Moderate

Cow's Milk Protein Allergy (CMPA)

IgE or Non-IgE Mediated Pediatric Food Hypersensitivity

Infants (usually presenting in the first 6 months of life)